Low Dose Statins, Ezetimibe and Nutraceuticals
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT03277079
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT03277079
-
- Other papers using this trial's data
- Usefulness of Low-Dose Statin Plus Ezetimibe and/or Nutraceuticals in Patients With Coronary Artery Disease Intolerant to High-Dose Statin Treatment
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT03277079. Randomized; single masking; primary purpose treatment. Start 2017-10-01 (anticipated); primary completion 2017-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Low Dose Statins, Ezetimibe and Nutraceuticals
- Acronym
- TACO
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- statin + ezetimibe
- Intervention (Drug)
- statin + ezetimibe + Nutraceuticals
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct03277079- Content hash
6de1dfe27fc153ffb9f3c69dc3513fffc58d547b20c899b27e2f1049b963e8f2